Connection
Christopher Wardell to Clinical Trials as Topic
This is a "connection" page, showing publications Christopher Wardell has written about Clinical Trials as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.021 |
|
|
|
-
Walker BA, Wardell CP, Melchor L, Hulkki S, Potter NE, Johnson DC, Fenwick K, Kozarewa I, Gonzalez D, Lord CJ, Ashworth A, Davies FE, Morgan GJ. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood. 2012 Aug 02; 120(5):1077-86.
Score: 0.021